Get started
Author

Stefan Pscherer

Observed names: Pscherer, S., Pscherer, Stefan, S Pscherer, S. PSCHERER, S. Pscherer, STEFAN PSCHERER
ORCID: 0009-0003-3400-5790
Observed ORCID: 0009-0003-3400-5790
OpenAlex ID: A5108574614
Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?
2012 · Sabrina Ehnert, Jian Zhao, et al. · BMC Medicine · 68
PDF
Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation – Description of a novel in vitro model
2015 · Sabrina Ehnert, Thomas Freude, et al. · Experimental Cell Research · 46
BMP9 a possible alternative drug for the recently withdrawn BMP7? New perspectives for (re-)implementation by personalized medicine
2016 · Vrinda Sreekumar, Romina Haydeé Aspera-Werz, et al. · Archives of Toxicology · 43
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
2016 · Karel Kostev, Stefan Pscherer, et al. · Diabetes Metabolic Syndrome and Obesity · 39
PDF
Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-β
2012 · Thomas Freude, Karl Friedrich Braun, et al. · Journal of Molecular Medicine · 36
Effect of Renin-Angiotensin System Blockade on Insulin Resistance and Inflammatory Parameters in Patients With Impaired Glucose Tolerance
2010 · Stefan Pscherer, Uwe Heemann, et al. · Diabetes Care · 36
Delayed Fracture Healing in Diabetics with Distal Radius Fractures
2017 · S. PSCHERER, G. H. SANDMANN, et al. · Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca · 25
PDF
Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis
2015 · Stefan Pscherer, Engels Chou, et al. · Primary care diabetes · 23
Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics
2013 · Stefan Pscherer, Thomas Freude, et al. · Diabetology & Metabolic Syndrome · 23
PDF
Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in Germany
2019 · Karel Kostev, Stefan Gölz, et al. · Journal of Diabetes Science and Technology · 21
PDF
Increased Oxidative Stress Response in Granulocytes from Older Patients with a Hip Fracture May Account for Slow Regeneration
2014 · Zhiyong Wang, Sabrina Ehnert, et al. · Oxidative Medicine and Cellular Longevity · 21
PDF
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs
2018 · Jochen Seufert, Andreas Fritsche, et al. · Diabetes Obesity and Metabolism · 17
Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting
2020 · Martin Pfohl, François R. Jornayvaz, et al. · Diabetes Obesity and Metabolism · 16
PDF
Comparison of one-year costs of Type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy (BOT) in Germany
2010 · S. Pscherer, E.S. Dietrich, et al. · International Journal of Clinical Pharmacology and Therapeutics · 16
Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses
2015 · Wolfgang Rathmann, Stefan Pscherer, et al. · Primary care diabetes · 14
Assessment of the Influence of Diabetes mellitus and Malnutrition on the Postoperative Complication Rate and Quality of Life of Patients in a Clinic Focused on Trauma Surgery
2018 · Elke Wintermeyer, Christoph Ihle, et al. · Zeitschrift für Orthopädie und Unfallchirurgie · 12
Gene expression changes in cancellous bone of type 2 diabetics: a biomolecular basis for diabetic bone disease
2014 · A. T. Haug, K. F. Braun, et al. · Langenbeck s Archives of Surgery · 12
Therapeutic peritoneal lavage with warm saline solution as an option for a critical hypothermic trauma patient
2013 · Thomas Freude, Sonja Gillen, et al. · Wiener klinische Wochenschrift · 12
Die Erfassung des Ernährungsstatus alterstraumatologischer Patienten – ein Vergleich zweier etablierter Screeningmethoden
2016 · C. Ihle, C. Bahrs, et al. · Zeitschrift für Orthopädie und Unfallchirurgie · 11
In Type 2 Diabetes Patients, Insulin Glargine is Associated with Lower Postprandial Release of Intact Proinsulin Compared with Sulfonylurea Treatment
2012 · Stefan Pscherer, Martin Larbig, et al. · Journal of Diabetes Science and Technology · 11
Composite efficacy parameters and predictors of hypoglycaemia in basal‐plus insulin therapy—a combined analysis of 713 type 2 diabetic patients
2013 · J. Seufert, H. Brath, et al. · Diabetes Obesity and Metabolism · 9
Switching the basal insulin to insulin glargine 300 U/ ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety
2021 · Jochen Seufert, Peter Wiesli, et al. · Diabetes Obesity and Metabolism · 8
PDF
Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study
2019 · Stefan Pscherer, Helmut Anderten, et al. · Acta Diabetologica · 8
Retrospektive Analyse von Diabetikern im Hinblick auf Behandlungsdauer und Behandlungskosten in einem überregionalen Traumazentrum
2016 · S. Pscherer, A. Nüssler, et al. · Zeitschrift für Orthopädie und Unfallchirurgie · 8
Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?
2016 · Sabrina Ehnert, Romina Haydée Aspera-Werz, et al. · European Surgical Research · 7
Works count: 72
Citation count: 598
H-index: 14
I10-index: 20
Year
Topic
Type